The expectations all around Europe were high on November 20 when representatives from the EU member states met to decide where the European Medicinal Agency should relocate. After a spectacular voting exercise, Amsterdam came out on top. The process to decide where to move the agency started officially in the early summer 2017 and intensified during the fall. Stockholm fell short in the end but the Swedish candidature made the regional collaboration to gain momentum during the year which hopefully will have positive effects on the life science sector in the region.
